Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Cash & Equivalents (2020 - 2025)

Ryan Specialty Holdings (RYAN) has disclosed Cash & Equivalents for 6 consecutive years, with $158.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 70.69% to $158.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $158.3 million through Dec 2025, down 70.69% year-over-year, with the annual reading at $158.3 million for FY2025, 70.69% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $158.3 million at Ryan Specialty Holdings, up from $153.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $2.0 billion in Q2 2023, with the low at $153.5 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2021.
  • The sharpest move saw Cash & Equivalents surged 393.09% in 2021, then tumbled 90.1% in 2025.
  • Over 5 years, Cash & Equivalents stood at $1.1 billion in 2021, then soared by 55.08% to $1.8 billion in 2022, then tumbled by 52.54% to $838.8 million in 2023, then tumbled by 35.6% to $540.2 million in 2024, then tumbled by 70.69% to $158.3 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $158.3 million, $153.5 million, and $172.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.